Get started
Work

FP07.05 DREAM3R: Durvalumab With Chemotherapy as First Line Treatment in Advanced Pleural Mesothelioma - A Phase 3 Randomised Trial

Year: 2021
Type: conference-abstract
DOI: 10.1016/j.jtho.2021.08.230
Authors: P. Forde, M. Stockler, P.S. Kok, C. Brown, Z. Sun, K. O'Byrne, S. Yip, V. Anagnostou, A. Cook, W.J. Lesterhuis, B. Hughes, H. Kindler, A. Tsao, M. Zauderer, A. Bricker, M. Oostendorp, D. Marinucci, K. Fitzpatrick, K. Ford, N. Pavlakis, J. Brahmer, S. Ramalingam, A. Nowak
Institutions: Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, The University of Sydney, Queensland University of Technology, Princess Alexandra Hospital, The University of Western Australia, The University of Queensland, Prince Charles Hospital, University of Chicago, The University of Texas MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, GenesisCare, Emory University, Sir Charles Gairdner Hospital
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W3207467727
Cites:
Cited by:
Related to: 10